Disclosure under Reg. 30 of SEBI (SAST) Regulation, 2011
Jagsonpal Pharmaceuticals Ltd has submitted to the Exchange vide letter dated October 03, 2018 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Scrutinizer''s Report 28-09-2018
Dear Sir, Sub.: submission of compliance 39th Annual general Meeting of the Company under Securities and Exchange Board of India (Listing Obligation and Disclosure requirements) regulation 2015. And Companies Act, 2013. Please be informed that the 39th Annual General Meeting (AGM) of the Company was held on 28 September 2018 at the i.e. at Vanita Samaj, 13, Institutional Area, New Delhi-110003.... Shareholder Meeting / Postal Ballot-Outcome of AGM
OUT-COME / PROCEEDINGS OF THE 39th ANNUAL GENERAL MEETING OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON 28.09.2018 AT 10.00 A.M. AT VANITA SAMAJ, LODHI ROAD, NEW DELHI - 110003. 1. Mr.Rajpal Singh Kochhar, Chairman and Managing Director took the Chair and welcomed the members to the 39th Annual General Meeting of the Company. 2. Mr. Rajpal Singh Kochhar then asked the Company Secretary to ascertain the quorum. After ascertaining... (1) Closure Of Register Of Members & Share Transfer Books (2) Annual General Meeting To Be Held On 28/09/202018 (3) Dividend If Approved.
Sir, Intimation for Closure of Register of Members & Share Transfer Books, Annual General Meeting of the Company and dividend if approved. Book Closure or record date 21/09/2018 to 28/09/2018. (Both days inclusive) Thanks, Outcome of Board Meeting
Outcome of Board Meeting held on August 09, 2018 in New Delhi to consider, Review and adopt the Unaudited Financial Results of the Company. Results - Unaudited Financial Results, June, 30, 2018
Unaudited Financial Results for the Quarter ended 30th June 2018 Board Meeting Intimation for Board Meeting To Held On 09.08.2018 To Consider Quarterly Results For The Period Ended 30.06.2018
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2018 ,inter alias, to consider and approve Dear Sir, Pursuant to Regulation 29 read with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby give notice that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, the 9th, August,... Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- R K KAPOORDesignation :- Company Secretary and Compliance Officer Shareholding for the Period Ended June 30, 2018
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here